Skip to content

Current ratio at other companies

Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
3.2×-2.8×
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
1.5×-0.2×
QuidelOrtho Corporation logo
QuidelOrtho CorporationQDEL
1.4×+0.2×
Revvity logo
RevvityRVTY
1.7×-1.9×
Biodesix, Inc. logo
Biodesix, Inc.BDSX
2.8×+0.6×
Agilent Technologies logo
Agilent TechnologiesA
2.1×0.0×

Other financials

Income statement

See full
Revenue$36.4M+20.1%
Gross profit$15.6M+4.9%
Operating income-$41.4M-56.9%
Net income-$17.5M+14.5%
EPS (diluted)-$0.37+30.2%

Balance sheet

See full
Cash & equivalents$36.2M-52.7%
Total debt$35.3M-2.9%
Total equity$282.1M-10.8%
Total assets$366.7M-7.5%

Cash flow

See full
Operating cash flow-$18.1M-30.4%
CapEx$87.0K-93.1%
Free cash flow-$18.2M-20.1%

Valuation

See full
Market cap$203.97M-20.1%
Enterprise value$203.12M+28.6%
P/S1.4×-0.6×

Profitability

See full
Gross margin44.2%-14.3pp
Operating margin-96.9%-1,691pp
Net margin-71.9%-2,019pp
FCF margin-57.2%-220pp

Returns & leverage

See full
Return on equity-34.8%-122pp
Debt / equity0.1×0.0×

Where this comes from

Calculated from Quanterix Corporation’s reported figures.

Based on the most recent quarter.

The official record: Quanterix Corporation’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Quanterix Corporation's current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Quanterix Corporation's current ratio?
Quanterix Corporation (QTRX) reported current ratio of 3.7× in Q1 2026.
How has Quanterix Corporation's current ratio changed year-over-year?
Quanterix Corporation's current ratio decreased by 55.1% year-over-year, from 8.3× to 3.7×.
What is the long-term trend for Quanterix Corporation's current ratio?
Over 5 years (2020 to 2025), Quanterix Corporation's current ratio has grown at a -12.4% compound annual growth rate (CAGR), from 5.5× to 2.8×.
What does current ratio mean?
Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.